In summary, AMPK ablation induces hyperproliferation and accelerates the development of CRC, likely mediated through epigenetic modifications, which is associated with reduced IDH content, decreased α-ketoglutarate production, and impaired TET2 activity. The gene discussed is PRKAA1; the disease is colorectal carcinoma.